Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Glutathione NAPQI , (thiol groups) , GSH
The peptide received FDA approval in June 2019 under the brand name Vyleesi for treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women, establishing it as a first-in-class medication with a novel mechanism distinct from all previous sexual dysfunction treatments
The coverage for the medication is provided through the Medicare GLP-1 Bridge program and is separate from your Medicare Part D prescription drug benefit
It's simpler than it looks, and it's all about understanding the relationship between the total amount of peptide, the amount of water you added, and the volume you'll draw into your syringe
Your clinician can help you determine which form and route of administration best fit your goals and dosing schedule
US$ 23.33
US$ 27.86
US$ 22.01
